Skip to main content

Table 2 Severity and Mortality Prediction Scores, ICU Therapies, and Pharmaceutical Treatments

From: Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave

Variable  
Scoring on ICU admission
 SOFA score 6 (3, 7)
 APACHE-II score 17 (13, 19)
 SAPS-II score 31 (21, 38)
ICU therapy
  Invasive mechanical ventilation 17 (71)
  Days of illness on intubation*, days 11 (10, 12)
  Nadir PaO2/FIO2 ratio* 169 (108, 183)
  Maximum positive end-expiratory pressure* 12 (10, 12)
  Prone positioning* 4 (24)
  Neuromuscular blockade* 2 (12)
  Extracorporeal membrane oxygenation* 1 (6)
 Inhaled nitrate oxide* 1 (6)
  Tracheostomy* 4 (24)
 Vasopressors 15 (63)
 Renal replacement therapy 2 (8)
 Enteral feeding within 24 h of ICU admission 16 (67)
 Enteral feeding within 48 h of ICU admission 19 (79)
Pharmaceutical Treatments
 Systemic steroids
  High-dose methylprednisolone 16 (67)
  Low-dose methylprednisolone 5 (21)
  No systemic steroid 3 (13)
 Antiviral agents
  Favipiravir 9 (38)
  Lopinavir/Ritonavir 4 (17)
 Antibacterial agents
  Piperacillin/Tazobactam and Azithromycin 7 (29)
  Piperacillin/Tazobactam and Levofloxacin 4 (17)
  Ceftriaxone and Azithromycin 10 (42)
  Ceftriaxone and Levofloxacin 1 (4)
  Ceftriaxone and Minocycline 1 (4)
  Ampicillin/Sulbactam and Azithromycin 1 (4)
 Anticoagulants
  Subcutaneous bolus injection of unfractionated heparin 6 (25)
  Intravenous continuous unfractionated heparin 12 (50)
  No anticoagulant 6 (25)
  1. SOFA Sequential Organ Failure Assessment, APACHE Acute Physiology and Chronic Health Evaluation, SAPS Simplified Acute Physiology Score, PaO2/FIO2 partial oxygen pressure/fraction inspired oxygen. Missing data: SAPS-II, 2
  2. Data are expressed as numbers (percentage), or median (interquartile range)
  3. * Measurements and treatments in mechanically ventilated patients are displayed
  4. †Initial combination of antibiotics use for the whole hospitalization course are shown
\